He will explain the risks, benefits, and potential outcomes of tirzepatide treatment to ensure informed decision-making
And employers, saddled with the impact of inflation and rising health-care costs, dont want to foot the bill
If you have a personal or family history of certain conditions, you shouldnt take any GLP-1 receptor agonist [7] speak to your healthcare provider about this before starting
Canada has released its first major update to pediatric obesity guidelines in nearly two decades, and the recommendations represent a dramatic departure from past approaches
Back Mallapaty, S, Nature Magazine (21 June 2024)'Cheaper versions of popular new weight-loss drugs are being developed', Scientific American
Side effects and safety considerations Tirzepatide produces side effects in most patients, though severity and specific symptoms vary widely